Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Mechanisms of erythrocyte development and regeneration: implications for regenerative medicine and beyond.

Bresnick EH, Hewitt KJ, Mehta C, Keles S, Paulson RF, Johnson KD.

Development. 2018 Jan 10;145(1). pii: dev151423. doi: 10.1242/dev.151423. Review.

PMID:
29321181
2.

Iron modulation of erythropoiesis is associated with Scribble-mediated control of the erythropoietin receptor.

Khalil S, Delehanty L, Grado S, Holy M, White Z 3rd, Freeman K, Kurita R, Nakamura Y, Bullock G, Goldfarb A.

J Exp Med. 2018 Feb 5;215(2):661-679. doi: 10.1084/jem.20170396. Epub 2017 Dec 27.

PMID:
29282252
3.

New pathogenic mechanisms induced by germline erythropoietin receptor mutations in primary erythrocytosis.

Pasquier F, Marty C, Balligand T, Verdier F, Grosjean S, Gryshkova V, Raslova H, Constantinescu SN, Casadevall N, Vainchenker W, Bellanné-Chantelot C, Plo I.

Haematologica. 2018 Apr;103(4):575-586. doi: 10.3324/haematol.2017.176370. Epub 2017 Dec 21.

4.

Correlated receptor transport processes buffer single-cell heterogeneity.

Kallenberger SM, Unger AL, Legewie S, Lymperopoulos K, Klingmüller U, Eils R, Herten DP.

PLoS Comput Biol. 2017 Sep 25;13(9):e1005779. doi: 10.1371/journal.pcbi.1005779. eCollection 2017 Sep. Erratum in: PLoS Comput Biol. 2018 Mar 1;14 (3):e1006037.

5.

Erythropoietin enhances Kupffer cell number and activity in the challenged liver.

Gilboa D, Haim-Ohana Y, Deshet-Unger N, Ben-Califa N, Hiram-Bab S, Reuveni D, Zigmond E, Gassmann M, Gabet Y, Varol C, Neumann D.

Sci Rep. 2017 Sep 4;7(1):10379. doi: 10.1038/s41598-017-11082-7.

6.

Direct targets of pSTAT5 signalling in erythropoiesis.

Gillinder KR, Tuckey H, Bell CC, Magor GW, Huang S, Ilsley MD, Perkins AC.

PLoS One. 2017 Jul 21;12(7):e0180922. doi: 10.1371/journal.pone.0180922. eCollection 2017.

7.

Cytokine Receptor Endocytosis: New Kinase Activity-Dependent and -Independent Roles of PI3K.

Chen PH, Yao H, Huang LJ.

Front Endocrinol (Lausanne). 2017 May 1;8:78. doi: 10.3389/fendo.2017.00078. eCollection 2017. Review.

8.

Plant-Produced Asialo-Erythropoietin Restores Pancreatic Beta-Cell Function by Suppressing Mammalian Sterile-20-like Kinase (MST1) and Caspase-3 Activation.

Arthur E, Kittur FS, Lin Y, Hung CY, Sane DC, Xie J.

Front Pharmacol. 2017 Apr 19;8:208. doi: 10.3389/fphar.2017.00208. eCollection 2017.

9.

Activating JAK2 mutants reveal cytokine receptor coupling differences that impact outcomes in myeloproliferative neoplasm.

Yao H, Ma Y, Hong Z, Zhao L, Monaghan SA, Hu MC, Huang LJ.

Leukemia. 2017 Oct;31(10):2122-2131. doi: 10.1038/leu.2017.1. Epub 2017 Jan 6.

10.

Oxygen-dependent Regulation of Erythropoietin Receptor Turnover and Signaling.

Heir P, Srikumar T, Bikopoulos G, Bunda S, Poon BP, Lee JE, Raught B, Ohh M.

J Biol Chem. 2016 Apr 1;291(14):7357-72. doi: 10.1074/jbc.M115.694562. Epub 2016 Feb 4.

11.

Emerging EPO and EPO receptor regulators and signal transducers.

Kuhrt D, Wojchowski DM.

Blood. 2015 Jun 4;125(23):3536-41. doi: 10.1182/blood-2014-11-575357. Epub 2015 Apr 17. Review.

12.

Using functional signature ontology (FUSION) to identify mechanisms of action for natural products.

Potts MB, Kim HS, Fisher KW, Hu Y, Carrasco YP, Bulut GB, Ou YH, Herrera-Herrera ML, Cubillos F, Mendiratta S, Xiao G, Hofree M, Ideker T, Xie Y, Huang LJ, Lewis RE, MacMillan JB, White MA.

Sci Signal. 2013 Oct 15;6(297):ra90. doi: 10.1126/scisignal.2004657.

13.

Cbl ubiquitination of p85 is essential for Epo-induced EpoR endocytosis.

Bulut GB, Sulahian R, Yao H, Huang LJ.

Blood. 2013 Dec 5;122(24):3964-72. doi: 10.1182/blood-2013-05-506212. Epub 2013 Oct 10.

14.

Eliminative signaling by Janus kinases: role in the downregulation of associated receptors.

Carbone CJ, Fuchs SY.

J Cell Biochem. 2014 Jan;115(1):8-16. doi: 10.1002/jcb.24647. Review.

15.

The erythropoietin receptor is a downstream effector of Klotho-induced cytoprotection.

Hu MC, Shi M, Cho HJ, Zhang J, Pavlenco A, Liu S, Sidhu S, Huang LJ, Moe OW.

Kidney Int. 2013 Sep;84(3):468-81. doi: 10.1038/ki.2013.149. Epub 2013 May 1.

16.

Regulation of Erythropoietin Receptor Activity in Endothelial Cells by Different Erythropoietin (EPO) Derivatives: An in Vitro Study.

Trincavelli ML, Da Pozzo E, Ciampi O, Cuboni S, Daniele S, Abbracchio MP, Martini C.

Int J Mol Sci. 2013 Jan 24;14(2):2258-81. doi: 10.3390/ijms14022258.

17.

The Jak/STAT signaling pathway is downregulated at febrile temperatures.

Nespital T, Strous GJ.

PLoS One. 2012;7(11):e49374. doi: 10.1371/journal.pone.0049374. Epub 2012 Nov 14.

18.

p85β regulatory subunit of class IA PI3 kinase negatively regulates mast cell growth, maturation, and leukemogenesis.

Krishnan S, Mali RS, Ramdas B, Sims E, Ma P, Ghosh J, Munugalavadla V, Hanneman P, Beane JD, Kapur R.

Blood. 2012 Apr 26;119(17):3951-61. doi: 10.1182/blood-2011-05-355602. Epub 2012 Feb 29.

19.

The clathrin assembly protein PICALM is required for erythroid maturation and transferrin internalization in mice.

Suzuki M, Tanaka H, Tanimura A, Tanabe K, Oe N, Rai S, Kon S, Fukumoto M, Takei K, Abe T, Matsumura I, Kanakura Y, Watanabe T.

PLoS One. 2012;7(2):e31854. doi: 10.1371/journal.pone.0031854. Epub 2012 Feb 21.

20.

Dynamic ligand modulation of EPO receptor pools, and dysregulation by polycythemia-associated EPOR alleles.

Singh S, Verma R, Pradeep A, Leu K, Mortensen RB, Young PR, Oyasu M, Schatz PJ, Green JM, Wojchowski DM.

PLoS One. 2012;7(1):e29064. doi: 10.1371/journal.pone.0029064. Epub 2012 Jan 12.

Supplemental Content

Support Center